Business News • PR NewsWire • Araim Pharmaceuticals' Cibinetide (ARA 290) Regenerates Small Nerve Fibers and Improves Neuropathic Clinical Symptoms in the Orphan Disease of Sarcoidosis

Araim Pharmaceuticals' Cibinetide (ARA 290) Regenerates Small Nerve Fibers and Improves Neuropathic Clinical Symptoms in the Orphan Disease of Sarcoidosis

Araim Pharmaceuticals' Cibinetide (ARA 290) Regenerates Small Nerve Fibers and Improves Neuropathic Clinical Symptoms in the Orphan Disease of Sarcoidosis

TARRYTOWN, N.Y., May 8, 2017 /PRNewswire/ -- Araim Pharmaceuticals Inc., today announced the publication of Phase 2b study results in small fiber neuropathy of the Company's lead compound within the Innate Repair Receptor activator platform (doi:10.1167/iovs.16-21291). Cibinetide...

View More : http://www.prnewswire.com/news-releases/araim-pharmaceuticals-cibinetide-ara-290-regenerates-small-nerve-fibers-and-impr...

Releted News by prnewswire

Storytel уже в России

Tokyo's New Logo and Slogan to Promote Tokyo Overseas as Prime Tourist Destination

Mayor Emanuel And Choose Chicago Announce Record Tourism In First Quarter Of 2017

Award-Winning Owner Acquires Orangetheory Fitness Shelton Studio Amidst Accelerated Connecticut Growth